These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9119979)

  • 21. Paraneoplastic cerebellar degeneration associated with Hodgkin's disease.
    Wessel K; Diener HC; Schroth G; Dichgans J
    J Neurol; 1987 Dec; 235(2):122-4. PubMed ID: 3430191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature.
    Gungor S; Kilic B; Arslan M; Ozgen U
    Childs Nerv Syst; 2017 Mar; 33(3):509-512. PubMed ID: 27796550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.
    Rodriguez M; Truh LI; O'Neill BP; Lennon VA
    Neurology; 1988 Sep; 38(9):1380-6. PubMed ID: 3045692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.
    Greenlee JE; Brashear HR
    Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease.
    Geromin A; Candoni A; Marcon G; Ferrari S; Sperotto A; De Luca S; Fanin R
    Leuk Lymphoma; 2006 Sep; 47(9):1960-3. PubMed ID: 17065013
    [No Abstract]   [Full Text] [Related]  

  • 27. [Paraneoplastic cerebellar degeneration].
    Nakano R; Sato S
    Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
    Anderson NE; Rosenblum MK; Posner JB
    Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia.
    Greenlee JE; Brashear HR; Herndon RM
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):561-71. PubMed ID: 3049946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein.
    Sakai K; Gofuku M; Kitagawa Y; Ogasawara T; Hirose G
    J Neuroimmunol; 1995 Jul; 60(1-2):135-41. PubMed ID: 7642741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.
    Ypma PF; Wijermans PW; Koppen H; Sillevis Smitt PA
    Neth J Med; 2006; 64(7):243-7. PubMed ID: 16929086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic cerebellar degeneration in association with Hodgkin's disease: a report of two cases.
    Cehreli C; Payzin B; Undar B; Yilmaz U; Alakavuklar MN
    Acta Haematol; 1995; 94(4):210-3. PubMed ID: 8610480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic cerebellar disorders.
    Baloh RW
    Otolaryngol Head Neck Surg; 1995 Jan; 112(1):125-7. PubMed ID: 7816446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
    Graus F; Segurado OG; Tolosa E
    Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration.
    Hida C; Tsukamoto T; Awano H; Yamamoto T
    Arch Neurol; 1994 Jun; 51(6):555-8. PubMed ID: 8198465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-Tr antibodies and cerebellar paraneoplastic degeneration associated with Hodgkin's disease].
    Graus F; Reñé R
    Neurologia; 1996; 11(7):261. PubMed ID: 8974427
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma.
    Saiz A; Dalmau J; Butler MH; Chen Q; Delattre JY; De Camilli P; Graus F
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):214-7. PubMed ID: 10071102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.